Cargando…

Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice

Influenza A virus (IAV) defective interfering particles (DIPs) are considered as new promising antiviral agents. Conventional DIPs (cDIPs) contain a deletion in the genome and can only replicate upon co-infection with infectious standard virus (STV), during which they suppress STV replication. We pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dogra, Tanya, Pelz, Lars, Boehme, Julia D., Kuechler, Jan, Kershaw, Olivia, Marichal-Gallardo, Pavel, Baelkner, Maike, Hein, Marc D., Gruber, Achim D., Benndorf, Dirk, Genzel, Yvonne, Bruder, Dunja, Kupke, Sascha Y., Reichl, Udo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684881/ https://www.ncbi.nlm.nih.gov/pubmed/38017026 http://dx.doi.org/10.1038/s41598-023-47547-1

Ejemplares similares

OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential
por: Hein, Marc D., et al.
Publicado: (2020)

Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles
por: Hein, Marc D., et al.
Publicado: (2021)

Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity
por: Rand, Ulfert, et al.
Publicado: (2021)

Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro
por: Pelz, Lars, et al.
Publicado: (2023)

Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture
por: Rüdiger, Daniel, et al.
Publicado: (2021)

Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy
por: Pelz, Lars, et al.
Publicado: (2021)

Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system
por: Hein, Marc D., et al.
Publicado: (2021)

Cell culture-based production of defective interfering particles for influenza antiviral therapy
por: Wasik, Milena A., et al.
Publicado: (2017)

Production of retroviral vectors in continuous high cell density culture
por: Hein, Marc D., et al.
Publicado: (2023)

A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome
por: Kupke, Sascha Young, et al.
Publicado: (2019)

Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles
por: Frensing, Timo, et al.
Publicado: (2013)

Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times—Insights From qPCR Measurements and Viral Dynamics Modeling
por: Tapia, Felipe, et al.
Publicado: (2019)

Single-Cell Analysis Uncovers a Vast Diversity in Intracellular Viral Defective Interfering RNA Content Affecting the Large Cell-to-Cell Heterogeneity in Influenza A Virus Replication
por: Kupke, Sascha Young, et al.
Publicado: (2020)

Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins
por: Pech, Sabine, et al.
Publicado: (2021)

Flow cytometric monitoring of influenza A virus infection in MDCK cells during vaccine production
por: Schulze-Horsel, Josef, et al.
Publicado: (2008)

Effect of influenza virus infection on key metabolic enzyme activities in MDCK cells
por: Janke, Robert, et al.
Publicado: (2011)

Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems
por: Tapia, Felipe, et al.
Publicado: (2017)

Metaproteomics of complex microbial communities in biogas plants
por: Heyer, Robert, et al.
Publicado: (2015)

A system for production of defective interfering particles in the absence of infectious influenza A virus
por: Bdeir, Najat, et al.
Publicado: (2019)

Impact of different influenza cultivation conditions on HA N-Glycosylation
por: Roedig, Jana V, et al.
Publicado: (2011)

Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production
por: Tapia, Felipe, et al.
Publicado: (2016)

Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection
por: Heldt, Frank S., et al.
Publicado: (2015)

Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions
por: Rüdiger, Daniel, et al.
Publicado: (2019)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
por: Jordan, Ingo, et al.
Publicado: (2013)

Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
por: Nikolay, Alexander, et al.
Publicado: (2018)

MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation
por: Genzel, Yvonne, et al.
Publicado: (2010)

Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model
por: Ramos, João Rodrigues Correia, et al.
Publicado: (2022)

Predicting compositions of microbial communities from stoichiometric models with applications for the biogas process
por: Koch, Sabine, et al.
Publicado: (2016)

In vivo Neutralization of Pro-inflammatory Cytokines During Secondary Streptococcus pneumoniae Infection Post Influenza A Virus Infection
por: Sharma-Chawla, Niharika, et al.
Publicado: (2019)

Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein
por: Ruhnau, Johannes, et al.
Publicado: (2021)

Metabolic effects of influenza virus infection in cultured animal cells: Intra- and extracellular metabolite profiling
por: Ritter, Joachim B, et al.
Publicado: (2010)

Impact of Host Cell Line Adaptation on Quasispecies Composition and Glycosylation of Influenza A Virus Hemagglutinin
por: Roedig, Jana Verena, et al.
Publicado: (2011)

High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system
por: Vázquez-Ramírez, Daniel, et al.
Publicado: (2019)

High-cell-density cultivations to increase MVA virus production
por: Vázquez-Ramírez, Daniel, et al.
Publicado: (2018)

Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion Mode
por: Coronel, Juliana, et al.
Publicado: (2020)

Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production
por: Gränicher, Gwendal, et al.
Publicado: (2020)

Performance of an acoustic settler versus a hollow fiber–based ATF technology for influenza virus production in perfusion
por: Gränicher, Gwendal, et al.
Publicado: (2020)

Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the “von Magnus effect”
por: Tapia, Felipe, et al.
Publicado: (2019)

Site-specific N-glycosylation analysis of animal cell culture-derived Zika virus proteins
por: Pralow, Alexander, et al.
Publicado: (2021)

The multidetector "CHIMERA" motherboards system
por: Nicotra, D, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_fdd8u5nrcg29c0iiieje64euhf